Innovation Pharmaceuticals Inc (IPIX): P was so promising to cancel interim and...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: JTORENCE post# 199265

Friday, 10/06/2017 4:48:02 PM

Friday, October 06, 2017 4:48:02 PM

P was so promising to cancel interim and tap Aspire for 2 more years? OM it is to save this investment. K/P both fading dreams.

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM

Only $200 per official company press release!